196 related articles for article (PubMed ID: 34115782)
1. Hybrid 2-[18F] FDG PET/MRI in premanifest Huntington's disease gene-expansion carriers: The significance of partial volume correction.
Hellem MNN; Vinther-Jensen T; Anderberg L; Budtz-Jørgensen E; Hjermind LE; Larsen VA; Nielsen JE; Law I
PLoS One; 2021; 16(6):e0252683. PubMed ID: 34115782
[TBL] [Abstract][Full Text] [Related]
2. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
[TBL] [Abstract][Full Text] [Related]
3. Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies.
Niccolini F; Pagano G; Fusar-Poli P; Wood A; Mrzljak L; Sampaio C; Politis M
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):185-196. PubMed ID: 28889093
[TBL] [Abstract][Full Text] [Related]
4. Huntingtin silencing delays onset and slows progression of Huntington's disease: a biomarker study.
Liu H; Zhang C; Xu J; Jin J; Cheng L; Miao X; Wu Q; Wei Z; Liu P; Lu H; van Zijl PCM; Ross CA; Hua J; Duan W
Brain; 2021 Nov; 144(10):3101-3113. PubMed ID: 34043007
[TBL] [Abstract][Full Text] [Related]
5. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
[TBL] [Abstract][Full Text] [Related]
6. Thalamic metabolism and symptom onset in preclinical Huntington's disease.
Feigin A; Tang C; Ma Y; Mattis P; Zgaljardic D; Guttman M; Paulsen JS; Dhawan V; Eidelberg D
Brain; 2007 Nov; 130(Pt 11):2858-67. PubMed ID: 17893097
[TBL] [Abstract][Full Text] [Related]
7. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
[TBL] [Abstract][Full Text] [Related]
8. Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington's disease.
Sampedro F; Martínez-Horta S; Perez-Perez J; Horta-Barba A; Lopez-Mora DA; Camacho V; Fernández-León A; Gomez-Anson B; Carrió I; Kulisevsky J
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1111-1116. PubMed ID: 30627816
[TBL] [Abstract][Full Text] [Related]
9. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.
Feigin A; Leenders KL; Moeller JR; Missimer J; Kuenig G; Spetsieris P; Antonini A; Eidelberg D
J Nucl Med; 2001 Nov; 42(11):1591-5. PubMed ID: 11696626
[TBL] [Abstract][Full Text] [Related]
10. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.
Politis M; Pavese N; Tai YF; Kiferle L; Mason SL; Brooks DJ; Tabrizi SJ; Barker RA; Piccini P
Hum Brain Mapp; 2011 Feb; 32(2):258-70. PubMed ID: 21229614
[TBL] [Abstract][Full Text] [Related]
11. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
Wu D; Faria AV; Younes L; Mori S; Brown T; Johnson H; Paulsen JS; Ross CA; Miller MI;
Hum Brain Mapp; 2017 Oct; 38(10):5035-5050. PubMed ID: 28657159
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI.
Michler E; Hoberück S; Martino F; Platzek I; Kotzerke J
Nuklearmedizin; 2019 Sep; 58(5):403-404. PubMed ID: 31344728
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease.
Delva A; Van Laere K; Vandenberghe W
Mov Disord; 2023 Aug; 38(8):1515-1526. PubMed ID: 37382295
[TBL] [Abstract][Full Text] [Related]
14. Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
Niccolini F; Haider S; Reis Marques T; Muhlert N; Tziortzi AC; Searle GE; Natesan S; Piccini P; Kapur S; Rabiner EA; Gunn RN; Tabrizi SJ; Politis M
Brain; 2015 Oct; 138(Pt 10):3016-29. PubMed ID: 26198591
[TBL] [Abstract][Full Text] [Related]
15. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
Ciarmiello A; Cannella M; Lastoria S; Simonelli M; Frati L; Rubinsztein DC; Squitieri F
J Nucl Med; 2006 Feb; 47(2):215-22. PubMed ID: 16455626
[TBL] [Abstract][Full Text] [Related]
16. FDG μPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington's Disease – A 15 Months Follow-up Study.
Reilmann R; Lippross V; Hölzner E; Gigengack F; Bohlen S; Kugel H; Deppe M; Osada N; Lücke M; Riess O; Nguyen HP; Von Hörsten S; Schäfers K; Schäfers M; Jacobs AH; Hermann S
J Huntingtons Dis; 2015; 4(1):37-47. PubMed ID: 26333256
[TBL] [Abstract][Full Text] [Related]
17. Magnetization transfer imaging in 'premanifest' Huntington's disease.
Jurgens CK; Bos R; Luyendijk J; Witjes-Ané MN; van der Grond J; Middelkoop HA; Roos RA
J Neurol; 2010 Mar; 257(3):426-32. PubMed ID: 19823894
[TBL] [Abstract][Full Text] [Related]
18. Metabolic network as a progression biomarker of premanifest Huntington's disease.
Tang CC; Feigin A; Ma Y; Habeck C; Paulsen JS; Leenders KL; Teune LK; van Oostrom JC; Guttman M; Dhawan V; Eidelberg D
J Clin Invest; 2013 Sep; 123(9):4076-88. PubMed ID: 23985564
[TBL] [Abstract][Full Text] [Related]
19. Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers.
Wilson H; Niccolini F; Haider S; Marques TR; Pagano G; Coello C; Natesan S; Kapur S; Rabiner EA; Gunn RN; Tabrizi SJ; Politis M
J Neurol Sci; 2016 Sep; 368():243-8. PubMed ID: 27538642
[TBL] [Abstract][Full Text] [Related]
20. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.
Henley SM; Wild EJ; Hobbs NZ; Scahill RI; Ridgway GR; Macmanus DG; Barker RA; Fox NC; Tabrizi SJ
J Neurol; 2009 Feb; 256(2):203-12. PubMed ID: 19266143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
